ENVVENO MEDICAL CORPORATION's ticker is and the CUSIP is 29415J106. A total of 23 filers reported holding ENVVENO MEDICAL CORPORATION in Q1 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $233,462 | +104.9% | 43,314 | +17.1% | 0.00% | – |
Q2 2023 | $113,917 | -15.8% | 36,986 | +28.0% | 0.00% | – |
Q1 2023 | $135,271 | -12.8% | 28,904 | -5.0% | 0.00% | – |
Q4 2022 | $155,193 | -23.6% | 30,430 | -5.7% | 0.00% | – |
Q3 2022 | $203,000 | +89.7% | 32,285 | +14.2% | 0.00% | – |
Q2 2022 | $107,000 | -53.5% | 28,280 | -21.3% | 0.00% | – |
Q1 2022 | $230,000 | -38.5% | 35,954 | -36.6% | 0.00% | – |
Q4 2021 | $374,000 | – | 56,730 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 401,200 | $1,517,000 | 2.12% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 219,180 | $829,000 | 0.14% |
Perceptive Advisors | 781,615 | $2,954,000 | 0.09% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 24,000 | $91,000 | 0.02% |
UBS OCONNOR LLC | 118,113 | $446,000,000 | 0.01% |
Sepio Capital, LP | 10,800 | $41,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 2,049 | $8,000 | 0.00% |
NORTHERN TRUST CORP | 13,906 | $53,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 81,723 | $308,000 | 0.00% |